Astrazeneca to retain Sweetness of Onglyza
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement…
Type 2 Diabetes
1 article